# Atossa Therapeutics, Inc.: Form 8-K, filed Apr 7, 2025

- Company: [Atossa Therapeutics, Inc.](/companies/atos.md) (CIK 1488039)
- Form: 8-K
- Filed: 2025-04-07
- Accepted by EDGAR: Apr 7, 2025, 20:05 ET
- Period: 2025-04-07
- Accession: 0000950170-25-051575
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1488039/000095017025051575/atos-20250407.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1488039/000095017025051575/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1488039/000095017025051575/atos-20250407.htm

Filed Apr 7, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-051575. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.